Cardiovascular Health in Pediatric Rheumatologic Diseases

Rheum Dis Clin North Am. 2022 Feb;48(1):157-181. doi: 10.1016/j.rdc.2021.09.006. Epub 2021 Oct 29.

Abstract

Cardiovascular disease risk is evident during childhood for patients with juvenile systemic lupus erythematosus, juvenile dermatomyositis, and juvenile idiopathic arthritis. The American Heart Association defines cardiovascular health as a positive health construct reflecting the sum of protective factors against cardiovascular disease. Disease-related factors such as chronic inflammation and endothelial dysfunction increase cardiovascular disease risk directly and through bidirectional relationships with poor cardiovascular health factors. Pharmacologic and nonpharmacologic interventions to improve cardiovascular health and long-term cardiovascular outcomes in children with rheumatic disease are needed.

Keywords: Cardiovascular disease; Cardiovascular health; Juvenile dermatomyositis; Juvenile idiopathic arthritis; Pediatric rheumatology; Systemic lupus erythematosus.

Publication types

  • Review

MeSH terms

  • Arthritis, Juvenile*
  • Arthritis, Rheumatoid*
  • Child
  • Dermatomyositis*
  • Humans
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / epidemiology
  • Rheumatic Diseases* / complications
  • Rheumatic Diseases* / epidemiology